{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:56:02Z","timestamp":1785866162792,"version":"3.56.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.genhosppsych.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:24:01Z","timestamp":1758939841000},"page":"82-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Psychosis in Huntington's disease: A systematic review of case reports"],"prefix":"10.1016","volume":"97","author":[{"given":"Aliu Opeyemi","family":"Yakubu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwakemi Eunice","family":"Olalude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olorungbami Kolade","family":"Anifalaje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses Gregory","family":"Effiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francess Oluwaferanmi","family":"Adeyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0005","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00005792-199709000-00001","article-title":"Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA)","volume":"76","author":"Ross","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp.74.1.120","article-title":"Behavioural abnormalities contribute to functional decline in Huntington\u2019s disease","volume":"74","author":"Hamilton","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0020","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1212\/01.WNL.0000052992.58107.67","article-title":"Predictors of nursing home placement in Huntington disease","volume":"60","author":"Wheelock","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0025","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Predict-HD investigators of the Huntington study group. Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1176\/appi.ajp.2015.14121551","article-title":"Longitudinal psychiatric symptoms in prodromal Huntington\u2019s disease: a decade of data","volume":"173","author":"Epping","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105166","article-title":"A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington\u2019s disease","volume":"149","author":"Clark","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0040","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4088\/JCP.v69n1116","article-title":"Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington\u2019s disease compared with mutation-negative first-degree relatives","volume":"69","author":"van Duijn","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/brainsci7060067","article-title":"Neuropsychiatric burden in Huntington\u2019s disease","volume":"7","author":"Paoli","year":"2017","journal-title":"Brain Sci"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.14802\/jmd.24140","article-title":"Evidence-based review on symptomatic management of Huntington\u2019s disease","volume":"17","author":"Shin","year":"2024","journal-title":"J Mov Disord"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0055","first-page":"26","article-title":"Update on the symptomatic treatment of Huntington\u2019s disease: from pathophysiology to clinical practice","author":"Olmedo-Saura","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0060","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0065","series-title":"JBI manual for evidence synthesis","article-title":"Chapter 7: Systematic reviews of etiology and risk","year":"2020"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5350\/DAJPN2014270308","article-title":"A case of Huntington\u2019s disease presenting with psychotic features","volume":"27","author":"Sengul","year":"2014","journal-title":"Dusunen Adam"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-0179-2-1","article-title":"Association of Huntington\u2019s disease and schizophrenia-like psychosis in a Huntington\u2019s disease pedigree","volume":"2","author":"Corr\u00eaa","year":"2006","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/OJP.OJP_11_24","article-title":"Huntington\u2019s disease associated with psychotic features","volume":"20","author":"Faizan","year":"2024","journal-title":"Odisha J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0085","series-title":"A double whammy: psychosis and huntington disease","first-page":"37","author":"Capote","year":"2020"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0090","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/appi.ajp.2008.08040503","article-title":"Aripiprazole effects on psychosis and chorea in a patient with Huntington\u2019s disease","volume":"165","author":"Lin","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0095","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/00048674211013082","article-title":"Clozapine treatment for Huntington\u2019s disease psychosis","volume":"56","author":"Bampton","year":"2022","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0100","first-page":"1353","article-title":"Clinical experience with risperidone and memantine in the treatment of Huntington\u2019s disease","volume":"98","author":"Cankurtoran","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202625","article-title":"Psychosis with Huntington\u2019s disease: role of antipsychotic medications","author":"Ding","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00004714-200208000-00020","article-title":"Rapid onset of tardive dyskinesia in Huntington disease with olanzapine","volume":"22","author":"Benazzi","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.ajp.2017.17060638","article-title":"Developmental delay, treatment-resistant psychosis, and early-onset dementia in a man with 22q11 deletion syndrome and Huntington\u2019s disease","volume":"175","author":"Farrell","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12662\/2317-3076jhbs.v9i1.3686.p1-3.2021","article-title":"Psychosis in Huntington\u2019s disease. A rare and under-investigated psychiatric manifestation","volume":"9","author":"Gon\u00e7alves","year":"2021","journal-title":"J Health Biol Sci"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0125","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM200009283431316","article-title":"Improvement of Huntington\u2019s disease with olanzapine and valproate","volume":"343","author":"Grove","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/aip.aip_195_22","article-title":"Psychosis and its linear outcomes: Huntington\u2019s disease","volume":"7","author":"Ankur","year":"2023","journal-title":"Ann Ind Psychiatr"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0135","first-page":"202","article-title":"Olanzapine in the management of psychosis in Huntington\u2019s disease: a case report","volume":"47","author":"Huarcaya-Victoria","year":"2019","journal-title":"Actas Esp Psiquiatr"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0140","article-title":"Huntington\u2019s disease with psychotic features","volume":"23","author":"Yeo","year":"2021","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0145","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4103\/jnrp.jnrp_453_16","article-title":"Predicting prognosis of psychosis in Huntington\u2019s disease: case report and review of literature","volume":"8","author":"Kar","year":"2017","journal-title":"J Neurosci Rural Pract"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/YPG.0000000000000359","article-title":"A rare case report of Huntington\u2019s disease with severe psychiatric symptoms as initial manifestations","volume":"34","author":"Lv","year":"2024","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0155","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/jmg.33.2.128","article-title":"Familial psychiatric presentation of Huntington\u2019s disease","volume":"33","author":"Lovestone","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/TPSY.TPSY_39_20","article-title":"Psychiatric manifestations in a patient with both Huntington\u2019s disease and hyperthyroidism: a case report","volume":"34","author":"Lai","year":"2020","journal-title":"Taiwan J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0165","first-page":"214","article-title":"Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington\u2019s disease","volume":"28","author":"Edlinger","year":"2013","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0170","first-page":"347","article-title":"Use of risperidone in psychosis associated with Huntington\u2019s disease","volume":"6","author":"Madhusoodanan","year":"1998","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pnp.664","article-title":"Treatment of psychosis in Huntington\u2019s disease with clozapine","volume":"24","author":"Majothi","year":"2020","journal-title":"Prog Neurol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0180","first-page":"17","article-title":"Prolonged psychosis before onset of neurological symptoms; an atypical clinical manifestation of Huntington\u2019s disease. Pakistan","author":"Mansoor","year":"2022","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/chi.0b013e31802ed8c9","article-title":"Huntington\u2019s disease presenting as a depressive disorder with psychotic features","volume":"46","author":"Jardri","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"361","key":"10.1016\/j.genhosppsych.2025.09.008_bb0190","first-page":"e3","article-title":"Acute psychosis in a verified Huntington disease gene carrier with subtle motor signs: psychiatric criteria should be considered for the diagnosis","volume":"36","author":"Nagel","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0195","article-title":"Clinical reasoning and challenges faced with onset psychotic symptoms in a case of combined Huntington\u2019s disease and Gayet-Wernicke encephalopathy","volume":"16","author":"Omri","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0200","doi-asserted-by":"crossref","DOI":"10.1176\/jnp.2010.22.3.352.e4","article-title":"Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington\u2019s disease","volume":"22","author":"Oulis","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0205","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/mds.21522","article-title":"Huntington\u2019s disease presenting as postsurgical psychosis","volume":"22","author":"Paganoni","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0210","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00004714-199704000-00023","article-title":"Risperidone in treatment of choreoathetosis of Huntington\u2019s disease","volume":"17","author":"Parsa","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0215","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/026988119601000213","article-title":"A comparative trial use of sulpiride and risperidone in Huntington\u2019s disease: a pilot study","volume":"10","author":"Reveley","year":"1996","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0220","first-page":"124","article-title":"Diagnostic difficulties in a patient with Huntington disease with schizophrenia like psychosis-A case report","volume":"17","author":"Rohilla","year":"2016","journal-title":"ASEAN J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0225","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1212\/WNL.41.1.156","article-title":"Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington\u2019s chorea","volume":"41","author":"Sajatovic","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.4547","article-title":"An unusual presentation of Huntington\u2019s disease","volume":"9","author":"Schulze Westhoff","year":"2021","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0235","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/070674370404900617","article-title":"Quetiapine in the management of psychosis secondary to Huntington\u2019s disease: a case report","volume":"49","author":"Seitz","year":"2004","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0240","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4103\/psychiatry.IndianJPsychiatry_111_19","article-title":"A rare case of Huntington\u2019s disease presenting with treatment-resistant psychosis","volume":"61","author":"Singhai","year":"2019","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0245","doi-asserted-by":"crossref","first-page":"302","DOI":"10.9758\/cpn.2016.14.3.302","article-title":"Psychosis, treatment emergent extrapyramidal events, and subsequent onset of Huntington\u2019s disease: a case report and review of the literature","volume":"14","author":"Xu","year":"2016","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0250","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1176\/appi.neuropsych.12040097","article-title":"Aripiprazole treatment for choreoathetoid and psychotic symptoms of Huntington\u2019s disease","volume":"25","author":"Yavuz","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"436","key":"10.1016\/j.genhosppsych.2025.09.008_bb0255","first-page":"e9","article-title":"Juvenile Huntington\u2019s disease presenting as difficult-to-treat seizure and the first episode of psychosis","volume":"34","author":"Chuo","year":"2012","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejpsy.2021.06.001","article-title":"A case of Huntington\u2019s disease presenting with psychotic symptoms and rapid cognitive decline in the early stage","volume":"36","author":"Chen","year":"2022","journal-title":"Eur J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0265","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JHD-190361","article-title":"Electroconvulsive therapy (ECT) for refractory psychiatric symptoms in Huntington\u2019s disease: a case series and review of the literature","volume":"8","author":"Adrissi","year":"2019","journal-title":"J Huntingtons Dis"},{"issue":"678","key":"10.1016\/j.genhosppsych.2025.09.008_bb0270","first-page":"e3","article-title":"Rapid improvement of depression and psychotic symptoms in Huntington\u2019s disease: a retrospective chart review of seven patients treated with electroconvulsive therapy","volume":"35","author":"Cusin","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0275","series-title":"Effectiveness of ECT in Huntington\u2019s disease with mood and psychotic symptoms: A case report","author":"Shokrgozar","year":"2025"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0280","first-page":"145","article-title":"ECT in the treatment of organic psychosis in Huntington\u2019s disease","volume":"3","author":"Evans","year":"1987","journal-title":"Convuls Ther"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0285","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/01.pra.0000456596.43492.48","article-title":"Emergency ECT in an incapacitated, medically compromised patient with Huntington\u2019s disease","volume":"20","author":"Magid","year":"2014","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0290","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/WNN.0b013e318240080d","article-title":"Westphal variant Huntington disease and refractory catatonia: a case report: a case report","volume":"24","author":"Merida-Puga","year":"2011","journal-title":"Cogn Behav Neurol"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0295","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/bjb.2020.51","article-title":"Electroconvulsive therapy for severe depression, psychosis and chorea in a patient with Huntington\u2019s disease: case report and review of the literature","volume":"45","author":"Mowafi","year":"2021","journal-title":"BJPsych Bull"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0300","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00415-012-6720-2","article-title":"Modified electroconvulsive therapy for the treatment of refractory schizophrenia-like psychosis associated with Huntington\u2019s disease","volume":"260","author":"Nakano","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0305","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1176\/appi.neuropsych.15040084","article-title":"Differential response to ECT of psychotic and affective symptoms in Huntington\u2019s disease: a case report","volume":"28","author":"Petit","year":"2016","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0310","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1192\/apt.bp.107.005371","article-title":"Psychiatric and behavioural manifestations of Huntington\u2019s disease","volume":"16","author":"Jauhar","year":"2010","journal-title":"Adv Psychiatr Treat"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0315","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fneur.2018.00930","article-title":"The clinical picture of psychosis in manifest Huntington\u2019s disease: a comprehensive analysis of the enroll-HD database","volume":"9","author":"Rocha","year":"2018","journal-title":"Front Neurol"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.09.008_bb0320","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1176\/appi.ajp.157.12.1955","article-title":"Familial aggregation of psychotic symptoms in Huntington\u2019s disease","volume":"157","author":"Tsuang","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0325","doi-asserted-by":"crossref","first-page":"e2395","DOI":"10.1212\/WNL.0000000000011893","article-title":"Timing and impact of psychiatric, cognitive, and motor abnormalities in Huntington disease","volume":"96","author":"McAllister","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0330","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.apnu.2021.03.006","article-title":"Lifetime neuropsychiatric symptoms in Huntington\u2019s disease: implications for psychiatric nursing","volume":"35","author":"Gibson","year":"2021","journal-title":"Arch Psychiatr Nurs"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0335","article-title":"Management of neuropsychiatric disturbances in Huntington\u2019s disease: a literature review and case report","volume":"25","author":"Jay","year":"2023","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/mds.22188","article-title":"A Europe-wide assessment of current medication choices in Huntington\u2019s disease","volume":"23","author":"Priller","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0345","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1590\/S0004-282X2004000600030","article-title":"Functional and motor response to low dose olanzapine in Huntington\u2019s disease: case report","volume":"62","author":"Laks","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0350","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00002826-200209000-00007","article-title":"Olanzapine for Huntington\u2019s disease: an open label study","volume":"25","author":"Bonelli","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0355","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/14656566.2021.1876666","article-title":"State-of-the-art pharmacological approaches to reduce chorea in Huntington\u2019s disease","volume":"22","author":"Gibson","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0360","first-page":"20","article-title":"Sialorrhea and aspiration pneumonia: a case study","volume":"10","author":"Trigoboff","year":"2013","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.genhosppsych.2025.09.008_bb0365","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3389\/fneur.2019.00710","article-title":"International guidelines for the treatment of Huntington\u2019s disease","volume":"10","author":"Bachoud-L\u00e9vi","year":"2019","journal-title":"Front Neurol"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325001872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325001872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:54:13Z","timestamp":1785862453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834325001872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":73,"alternative-id":["S0163834325001872"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.09.008","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychosis in Huntington's disease: A systematic review of case reports","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}